NCT02723721 2026-03-24
PICAMEL
Centre Hospitalier Universitaire de Nice
Phase 2 Completed
Clinical Trials
7 trialsNCT02394132 2024-06-20
RADICAL
Melanoma and Skin Cancer Trials Limited
Phase 3 Completed
NCT01088737 2019-08-13
Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna
Medical University of Graz
Phase 2/3 Unknown
NCT02306512 2019-01-07
Mohs and Immunofluorescence for Malignant Melanoma In Situ
University of Miami
Phase NA Withdrawn
NCT02685592 2018-05-30
LM PDT
Joint Authority for Päijät-Häme Social and Health Care
Phase 4 Completed
NCT00707174 2013-07-31
Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna
University of Utah
Phase NA Completed
NCT01161888 2012-06-20
LIMIT-1
University Hospital Birmingham NHS Foundation Trust
Phase 4 Completed